Radio-guided resection of non-palpable rectal carcinoma following polypectomyMERSICH, Tamas; LANG, Istvan; BALOGH, Ildiko et al.Hepato-gastroenterology. 2007, Vol 54, Num 75, pp 751-752, issn 0172-6390, 2 p.Article

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS TrialAJANI, Jaffer A; RODRIGUEZ, Wuilbert; BODOKY, Gyorgy et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1547-1553, issn 0732-183X, 7 p.Article

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracilHITRE, Erika; BUDAI, Barna; KASLER, Miklos et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 10, pp 723-730, issn 1744-6872, 8 p.Article

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancerMARTIN, Miguel; BONNETERRE, Jacques; KONGMING WANG et al.European journal of cancer (1990). 2013, Vol 49, Num 18, pp 3763-3772, issn 0959-8049, 10 p.Article

Endocrine disrupting chemicals in Hungarian canned foodsYAMAMOTO, Masaharu; LANG, Istvan; SAKAI, Hiroshi et al.Environmental health and preventive medicine. 2002, Vol 6, Num 4, pp 273-275, issn 1342-078XArticle

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorinLANG, Istvan; KÖHNE, Claus-Henning; FOLPRECHT, Gunnar et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 439-448, issn 0959-8049, 10 p.Article

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerPICCART-GEBHART, Martine J; PROCTER, Marion; CAMERON, David et al.The New England journal of medicine. 2005, Vol 353, Num 16, pp 1659-1672, issn 0028-4793, 14 p.Article

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialGOSS, Paul E; INGLE, James N; D'SOUZA, David P et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1398-1404, issn 0732-183X, 7 p.Article

Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel : Breast International Group 02-98 Randomized TrialFRANCIS, Prudence; CROWN, John; GUTIERREZ, Jorge et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 2, pp 121-133, issn 0027-8874, 13 p.Article

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI + bevacizumabBUDAI, Barna; KOMLOSI, Viktor; ADLEFF, Vilmos et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 1, pp 69-72, issn 1744-6872, 4 p.Article

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation StatusVAN CUTSEM, Eric; KÖHNE, Claus-Henning; SCHLICHTING, Michael et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2011-2019, issn 0732-183X, 9 p.Article

Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 StudyCOLLEONI, Marco; GIOBBIE-HURDER, Anita; CHIRGWIN, Jacquie et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1117-1124, issn 0732-183X, 8 p.Article

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 TrialEWERTZ, Marianne; GRAY, Kathryn P; GELBER, Richard D et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 3967-3975, issn 0732-183X, 9 p.Article

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast CancerPAGANI, Olivia; REGAN, Meredith M; CIRUELOS, Eva et al.The New England journal of medicine. 2014, Vol 371, Num 2, pp 107-118, issn 0028-4793, 12 p.Article